Sequencing-Based Gene Panels Help Diagnose, Guide Treatment, AACC Presenters Say | GenomeWeb

ATLANTA (GenomeWeb) – Gene panel testing is enabling clinicians to classify cancer patients' disease and identify potential treatment courses, according to presenters at the American Association for Clinical Chemistry meeting, held here this week.

As more gene variants are linked to various forms of cancer and more drugs are targeted to those specific forms of disease, clinicians need a way to identify patients whose tumors harbor these mutations and who may benefit from targeted therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.

Sponsored by
Agilent Technologies

This webinar will discuss a genomic strategy that detects single nucleotide variants and copy number variants in a single assay.

Sponsored by

This webinar will be an interactive roundtable discussion on established and emerging regulatory, scientific, and medical topics related to next-generation sequencing in the clinical setting.